Catherine M Lockhart

6PUBLICATIONS
16CO-AUTHORS
Predictive and prognostic markersRegenerative medicine (incl. stem cells)PharmacogenomicsMedical biotechnology diagnostics (incl. biosensors)Translational and applied bioinformatics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 08, 2023
Identification of cancer chemotherapy regimens and patient cohorts in administrative claims: challenges, opportunities, and a proposed algorithm.

Catherine M Lockhart, Cara L McDermott, Aaron B Mendelsohn

|Jan 31, 2021
Patient Characteristics and Utilization Patterns of Short-Acting Recombinant Granulocyte Colony-Stimulating Factor (G-CSF) Biosimilars Compared to Their Reference Product.

Aaron B Mendelsohn, James Marshall, Cara L McDermott

|Dec 29, 2020
Utilization patterns and characteristics of users of biologic anti-inflammatory agents in a large, US commercially insured population.

Aaron B Mendelsohn, Young Hee Nam, James Marshall

|Dec 20, 2019
Mapping from the International Classification of Diseases (ICD) 9th to 10th Revision for Research in Biologics and Biosimilars Using Administrative Healthcare Data.

Mengdong He, Adrian J Santiago Ortiz, James Marshall

|Dec 06, 2019
Capture of biologic and biosimilar dispensings in a consortium of U.S.-based claims databases: Utilization of national drug codes and Healthcare Common Procedure Coding System modifiers in medical claims.

Jie Zhang, Kevin Haynes, Aaron B Mendelsohn

|Aug 13, 2019
Barriers and facilitators to conduct high-quality, large-scale safety and comparative effectiveness research: The Biologics and Biosimilars Collective Intelligence Consortium experience.

Catherine M Lockhart, Cara L McDermott, Thomas Felix

Pageof 1

Frequent Collaborators

3 joint publications

Aaron B Mendelsohn

3 joint publications

Cara L McDermott

2 joint publications

Jeffrey S Brown

2 joint publications

Pamala A Pawloski